Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism VSTM1 agonists(V-set and transmembrane domain containing 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | 12 Dec 2022 | |
Pulmonary Disease, Chronic Obstructive | Preclinical | US | 12 Dec 2022 |